EUVIMEDEUVIMED entdecken
Crossref

Engineered probiotics recruit CAR macrophages and establish immune memory to eradicate heterogeneous glioblastoma in mice

Yulin Zhang, Jianyu Shen, Yu Xu, Fan Feng, Xu Han, Kaiyan Xi, Zezheng Fang, Yi Zhang, Mingrui Wang, Zixu Wang, Pengfei Zhu, Qikang Zhang und 20 weitere

Cell Host & Microbe · 2026-02 · 34 (2) · 212-229.e7

DOI: 10.1016/j.chom.2025.12.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2026-02. Verfasst von Yulin Zhang und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Qilu Hospital of Shandong University, Shandong Key Laboratory of Brain Health and Function Remodeling, Institute of Brain…. Hauptthemen laut MEDLINE: Probiotics, Macrophages, Immunotherapy, Glioblastoma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Taishan Scholar Foundation of Shandong Province, National Natural Science Foundation of China, Key Technology Research and Development Program of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) remains a highly lethal form of cancer due to its molecular heterogeneity and the immunosuppressive microenvironment surrounding the tumor. Here, we report a modular immunotherapy platform characterized by its flexibility to simultaneously target multiple antigens. Specifically, we utilize engineered E. coli Nissle to colonize tumors and produce bispecific engagers that simultaneously target EGFRvIII and interleukin (IL)-13Rα2. These tags direct in situ-reprogrammed chimeric antigen receptor (CAR) macrophages, which are edited using nanoparticles and delivered within a shear-thinning hydrogel, to execute targeted phagocytosis. This probiotic-macrophage crosstalk eliminates tumor cells while converting protumor M2 macrophages into immunostimulatory M1 effectors. In aggressive orthotopic GBM mouse models, this strategy achieves 83% survival at the 120-day endpoint, representing a 5-fold improvement over single-target controls and establishing durable immunological memory that effectively combats recurrence. By functioning as multifunctional immune hubs, this platform offers a versatile framework designed to overcome the antigenic complexity of solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsMacrophagesImmunotherapyGlioblastomaEscherichia coliReceptors, Chimeric AntigenImmunologic MemoryTumor MicroenvironmentBrain NeoplasmsAnimalsMicePhagocytosisErbB ReceptorsInterleukin-13 Receptor alpha2 SubunitCell EngineeringNeoplasms, ExperimentalCell Line, TumorRAW 264.7 CellsHEK293 CellsHumansMaleNeoplasm Recurrence, Local

Stichwörter der Autor:innen

CAR macrophagesengineered probioticsglioblastomaimmunotherapyin situ gene editingmicrobial immunotherapyorthotopic modelstumor microenvironment

Substanzen

Receptors, Chimeric AntigenErbB ReceptorsInterleukin-13 Receptor alpha2 Subunit

Autor:innen und Institutionen

  • Department of Neurosurgery, Qilu Hospital of Shandong University, Shandong Key Laboratory of Brain Health and Function Remodeling, Institute of Brain and Brain-Inspired Science, Jinan Microecological Biomedicine Shandon…
  • Faculty of Medicine and Health Sciences, School of Pharmacy, University of Auckland, Auckland 1023, New Zealand.
  • Department of Emergency Medicine, Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, Medical and Pharmaceu…
  • Department of Biological Sciences, Middle East Technical University, Universiteler Mah. Dumlupınar Bulvarı 1, Çankaya, Ankara 06800, Turkey.
  • University of Bordeaux, CNRS, IBGC UMR5095, Bordeaux, France.
  • Department of Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.

Förderung

  • Taishan Scholar Foundation of Shandong Province
  • National Natural Science Foundation of China
  • Key Technology Research and Development Program of Shandong Province
  • Shandong Province Natural Science Foundation

Zitieren

APA

Zhang, Y., Shen, J., Xu, Y., Feng, F., Han, X., Xi, K., Fang, Z., Zhang, Y., Wang, M., Wang, Z., Zhu, P., Zhang, Q., Li, Z., Liu, B., Cao, Z., Wang, C., Xu, Q., Yu, Y., Sun, C., …, & Jiang, X. (2026). Engineered probiotics recruit CAR macrophages and establish immune memory to eradicate heterogeneous glioblastoma in mice. Cell Host & Microbe, 34(2), 212-229.e7. https://doi.org/10.1016/j.chom.2025.12.014

Vancouver

Zhang Y, Shen J, Xu Y, Feng F, Han X, Xi K, et al. Engineered probiotics recruit CAR macrophages and establish immune memory to eradicate heterogeneous glioblastoma in mice. Cell Host & Microbe. 2026;34(2):212-229.e7. doi:10.1016/j.chom.2025.12.014

BibTeX
@article{Zhang2026,
  author = {Zhang, Yulin and Shen, Jianyu and Xu, Yu and Feng, Fan and Han, Xu and Xi, Kaiyan and Fang, Zezheng and Zhang, Yi and Wang, Mingrui and Wang, Zixu and Zhu, Pengfei and Zhang, Qikang and Li, Zhiqiang and Liu, Baichuan and Cao, Zeyue and Wang, Chaoqun and Xu, Qianen and Yu, Yang and Sun, Chengpeng and Wang, Xinrui and Wang, Jingjing and Pang, Jiaojiao and Wu, Zimei and Geng, Huimin and Acar, Ahmet and Daubon, Thomas and Zhang, Wenli and Zhang, Yanrong and Li, Xingang and Chen, Yuguo and Ni, Shilei and Jiang, Xinyi},
  title = {Engineered probiotics recruit CAR macrophages and establish immune memory to eradicate heterogeneous glioblastoma in mice},
  journal = {Cell Host & Microbe},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {212--229.e7},
  doi = {10.1016/j.chom.2025.12.014}
}
Kostenlos starten →